Genenta Science SPA (GNTA)
3.225
0.00 (0.00%)
USD |
NASDAQ |
Jun 20, 16:00
Genenta Science Shareholders Equity (Quarterly): 22.59M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.59M |
| June 30, 2023 | 26.96M |
| June 30, 2023 | 26.96M |
| December 31, 2022 | 33.39M |
| June 30, 2022 | 38.64M |
| Date | Value |
|---|---|
| June 30, 2022 | 38.64M |
| December 31, 2021 | 44.00M |
| June 30, 2021 | 13.81M |
| June 30, 2021 | 13.81M |
| December 31, 2020 | 18.64M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
13.81M
Minimum
Jun 2021
44.00M
Maximum
Dec 2021
27.74M
Average
26.96M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Stevanato Group SPA | 1.437B |
| Lipocine Inc | 23.96M |
| Relmada Therapeutics Inc | 72.05M |
| FibroGen Inc | -228.12M |
| NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.70M |
| Total Liabilities (Quarterly) | 2.117M |